Patient characteristics among R1 randomization arms
| . | DNR arm . | IDA arm . | P value . |
|---|---|---|---|
| No. patients | 209 | 207 | NA |
| Median age, y | 72 | 72 | .91 |
| AML type, no. patients | |||
| de novo AML | 179 | 174 | .68 |
| post-MDS AML | 30 | 33 | |
| Median WBC count, × 109/L | 5.5 | 5 | .69 |
| Karyotype, no. patients | |||
| Not done | 11 | 16 | .33 |
| Failure | 36 | 14 | .001 |
| Standard-risk | 137 | 153 | .07 |
| High-risk | 25 | 24 | .99 |
| . | DNR arm . | IDA arm . | P value . |
|---|---|---|---|
| No. patients | 209 | 207 | NA |
| Median age, y | 72 | 72 | .91 |
| AML type, no. patients | |||
| de novo AML | 179 | 174 | .68 |
| post-MDS AML | 30 | 33 | |
| Median WBC count, × 109/L | 5.5 | 5 | .69 |
| Karyotype, no. patients | |||
| Not done | 11 | 16 | .33 |
| Failure | 36 | 14 | .001 |
| Standard-risk | 137 | 153 | .07 |
| High-risk | 25 | 24 | .99 |
NA indicates not applicable.